Maiwald in the press

Press Coverage

Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million

Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of AficamtenRoyalty Pharma Purchases Royalties on Future Sales of Aficamten

Continue reading

Royalty Pharma Acquires Additional Royalty Interests in bcx9930 and Orladeyo From Biocryst Pharmaceuticals

Royalty Pharma plc (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and OMERS Capital Markets (OMERS) today announced transactions totaling $350 million in new funding for BioCryst, with all funds immediately available at closing.

Continue reading

Preparing Clients for the Future

A European Unitary Patent and a Unified Patent Court: The EU aims to create a European Unitary Patent with uniform effect in all member states of the European Union. There are still political and legal debates, but no one doubts that the EU Unitary Patent will come one day.

Continue reading

All press coverage

Maiwald press releases

Video Conference Without Consent of the Parties – Amicus Curiae Brief Filed in Connection With Case G 1/21 Before the Enlarged Board of Appeal of the Epo

Maiwald, together with other leading patent law firms, considers video conferencing without the consent of the parties to be inadmissible and has filed an amicus curiae brief in connection with the proceedings G 1/21 before the Enlarged Board of Appeal of the Europea...

Continue reading

Maiwald establishes practice for patent litigation in the field of standard-essential HEVC patents and video codec technologies against non-practicing entities

Maiwald is setting up a patent litigation team with partner Dr Simon Lud and two associates. Maiwald is mandated by Unified Patents, LLC, located in the USA.

Continue reading

Assignment of Phoma macrostoma Patents to Evologic Technologies

Her Majesty the Queen in Right of Canada, as represented by the Canadian Minister of Agriculture and Agri-Food (“AAFC”) and Evologic Technologies GmbH have entered into an assignment and licence agreement regarding the Phoma macrostoma technology.

Continue reading

All press releases

Press Contact

Dr Eva Dörner


German Patent Attorney

European Patent Attorney